Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04FFS
|
|||
| Former ID |
DNC010421
|
|||
| Drug Name |
Benzaldehyde O-4-(pentyloxy)phenylcarbamoyl oxime
|
|||
| Synonyms |
CHEMBL598244; benzaldehyde O-4-(pentyloxy)phenylcarbamoyl oxime
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H22N2O3
|
|||
| Canonical SMILES |
CCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2
|
|||
| InChI |
1S/C19H22N2O3/c1-2-3-7-14-23-18-12-10-17(11-13-18)21-19(22)24-20-15-16-8-5-4-6-9-16/h4-6,8-13,15H,2-3,7,14H2,1H3,(H,21,22)/b20-15+
|
|||
| InChIKey |
RMGKIVHTNJBERM-HMMYKYKNSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.